Daily BriefsECM

Daily Brief ECM: Hoshino Resorts REIT Placement – Another Raising to Fund an Accretive Acquisition and more

In today’s briefing:

  • Hoshino Resorts REIT Placement – Another Raising to Fund an Accretive Acquisition
  • ECM Weekly (27th May 2024) – Renesas, AUB, Modec, Tata Tech, MUFG, Shift Up, Novelis, Shulan
  • Jiangxi Rimag IPO: FCF Generation and Margin Expansion. Expect ~30 New Imaging Centers By 2026


Hoshino Resorts REIT Placement – Another Raising to Fund an Accretive Acquisition

By Clarence Chu

  • Hoshino Resorts Reit (3287 JP) is looking to raise US$125m from a primary follow-on. Proceeds will be used to acquire the OMO7 Osaka asset.
  • The REIT has been active on the acquisition front, undertaking a number of capital raisings in recent years.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

ECM Weekly (27th May 2024) – Renesas, AUB, Modec, Tata Tech, MUFG, Shift Up, Novelis, Shulan

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • On the IPO front, Go Digit managed to do well despite somewhat tepid subscription rates, while Shift Up (462870 KS) was looking to be the next hot listing in Korea.
  • On the placement front, Renesas Electronics (6723 JP) mega-block kept the cross-shareholding unwind going.

Jiangxi Rimag IPO: FCF Generation and Margin Expansion. Expect ~30 New Imaging Centers By 2026

By Andrei Zakharov

  • Jiangxi Rimag Group, China’s largest medical group with focus on medical imaging services, updated its PHIP and may enter the public market in June.
  • Terms of an IPO have not yet been set. The expected price range and the size of the offering were not disclosed in the company’s filings. 
  • I’m positive on Jiangxi Rimag Group given the fast-growing TAM: third-party medical imaging center market accounts only for ~1% of the PRC medical imaging service market today.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars